Maternal HIV and Paediatric Lung Health

Paediatric Respiratory Reviews

Volumn 21, Issue , 2017, Pages 47-53

  Slogrove, A L ^a   Frigati, L ^b   Gray, D M ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

HIV; infant; maternal exposure; respiratory disease

Indexed keywords

ANTIRETROVIRUS AGENT; TENOFOVIR; ZIDOVUDINE;

BREAST FEEDING; CHILD; CHILD HEALTH; CHILD HEALTH CARE; DISEASE SEVERITY; HEALTH HAZARD; HIGH RISK INFANT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LOW BIRTH WEIGHT; LOWER RESPIRATORY TRACT INFECTION; LUNG INJURY; MENTAL STRESS; PNEUMONIA; PREMATURITY; REVIEW; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; WELLBEING; CYTOMEGALOVIRUS INFECTIONS; DIAGNOSTIC IMAGING; EMBRYOLOGY; FEMALE; GROWTH, DEVELOPMENT AND AGING; HIV INFECTIONS; IMMUNOLOGY; LUNG; NEWBORN; PNEUMOCOCCAL INFECTIONS; PNEUMONIA, PNEUMOCYSTIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE; RESPIRATORY TRACT DISEASES; SOCIOECONOMICS; TUBERCULOSIS;

ANTI-RETROVIRAL AGENTS; BREAST FEEDING; CHILD; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; LUNG; PNEUMOCOCCAL INFECTIONS; PNEUMONIA, PNEUMOCYSTIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; RESPIRATORY TRACT DISEASES; SOCIOECONOMIC FACTORS; TUBERCULOSIS;

EID: 84994476409     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2016.08.004     Document Type: Review

References (64)

1. [1] Barker, D.J., Godfrey, K.M., Fall, C., Osmond, C., Winter, P.D., Shaheen, S.O., Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ 303 (1991), 671–675.
2. [2] UNAIDS. GLOBAL REPORT: UNAIDS report on the global AIDS epidemic 2013; 2013.
3. [3] Goga AE, Dinh TH, Jackson DJ. Evaluation of the effectiveness of the national prevention of mother-to-child transmission (PMTCT) programme on infants HIV measured at six weeks postpartum in South Africa. 2010. Available from: http://sanac.org.za/resources/cat_view/7-publications/9-reports.
4. [4] Evans, C., Jones, C.E., Prendergast, A.J., HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination. Lancet Infect Dis, 2016.
5. [5] Liu, L., Oza, S., Hogan, D., Perin, J., Rudan, I., Lawn, J.E., et al. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 385 (2015), 430–440.
6. [6] Walker, C.L., Rudan, I., Liu, L., Nair, H., Theodoratou, E., Bhutta, Z.A., et al. Global burden of childhood pneumonia and diarrhoea. Lancet 381 (2013), 1405–1416.
7. [7] Gray, D.M., Zar, H.J., Community-acquired pneumonia in HIV-infected children: a global perspective. Curr Opin Pulm Med 16 (2010), 208–216.
8. [8] Weber, H.C., Gie, R.P., Cotton, M.F., The challenge of chronic lung disease in HIV-infected children and adolescents. J Int AIDS Soc, 16, 2013, 18633.
9. [9] Mofenson, L.M., Watts, D.H., Safety of pediatric HIV elimination: the growing population of HIV- and antiretroviral-exposed but uninfected infants. PLoS Med, 11, 2014, e1001636.
10. [10] Bunders, M.J., van Hamme, J.L., Jansen, M.H., Boer, K., Kootstra, N.A., Kuijpers, T.W., Fetal exposure to HIV-1 alters chemokine receptor expression by CD4+T cells and increases susceptibility to HIV-1. Sci Rep, 4, 2014, 6690.
11. [11] Chen, J.Y., Ribaudo, H.J., Souda, S., Parekh, N., Ogwu, A., Lockman, S., et al. Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana. J Infect Dis 206 (2012), 1695–1705.
12. [12] Baraldi, E., Filippone, M., Chronic lung disease after premature birth. N Engl J Med 357 (2007), 1946–1955.
13. [13] McEvoy, C., Venigalla, S., Schilling, D., Clay, N., Spitale, P., Nguyen, T., Respiratory function in healthy late preterm infants delivered at 33–36 weeks of gestation. J Pediatr 162 (2013), 464–469.
14. [14] Svanes, C., Omenaas, E., Heuch, J.M., Irgens, L.M., Gulsvik, A., Birth characteristics and asthma symptoms in young adults: results from a population-based cohort study in Norway. Eur Respir J 12 (1998), 1366–1370.
15. [15] Stein, C.E., Kumaran, K., Fall, C.H., Shaheen, S.O., Osmond, C., Barker, D.J., Relation of fetal growth to adult lung function in south India. Thorax 52 (1997), 895–899.
16. [16] Lamberti, L.M., Zakarija-Grkovic, I., Fischer Walker, C.L., Theodoratou, E., Nair, H., Campbell, H., et al. Breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two: a systematic literature review and meta-analysis. BMC Public Health, 13(Suppl. 3), 2013, S18.
17. [17] Black, R.E., Allen, L.H., Bhutta, Z.A., Caulfield, L.E., de Onis, M., Ezzati, M., et al. Maternal and child undernutrition: global and regional exposures and health consequences. Lancet 371 (2008), 243–260.
18. [18] Jackson, D.J., Gangnon, R.E., Evans, M.D., Roberg, K.A., Anderson, E.L., Pappas, T.E., et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 178 (2008), 667–672.
19. [19] Humphrey, J.H., The risks of not breastfeeding. J Acquir Immune Defic Syndr 53 (2010), 1–4.
20. [20] Kuhn, L., Kasonde, P., Sinkala, M., Kankasa, C., Semrau, K., Scott, N., et al. Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants?. Clin Infect Dis 41 (2005), 1654–1661.
21. [21] Kuhn, L., Aldrovandi, G.M., Sinkala, M., Kankasa, C., Semrau, K., Mwiya, M., et al. Effects of early, abrupt weaning on HIV-free survival of children in Zambia. N Engl J Med 359 (2008), 130–141.
22. [22] Guideline on when to start antiretroviral therapy and on pre-exposure prohpylaxis for HIV; 2015.
23. [23] Verani, J.R., Groome, M.J., Zar, H.J., Zell, E.R., Kapongo, C.N., Nzenze, S.A., et al. Risk factors for presumed bacterial pneumonia among HIV-uninfected children hospitalized in Soweto, South Africa. Pediatr Infect Dis J, 2016.
24. [24] Lawn, S.D., Bekker, L.G., Middelkoop, K., Myer, L., Wood, R., Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions. Clin Infect Dis 42 (2006), 1040–1047.
25. [25] Guibert, G., Warszawski, J., Le Chenadec, J., Blanche, S., Benmebarek, Y., Mandelbrot, L., et al. Decreased risk of congenital cytomegalovirus infection in children born to HIV-1-infected mothers in the era of highly active antiretroviral therapy. Clin Infect Dis 48 (2009), 1516–1525.
26. [26] McNally, L.M., Jeena, P.M., Lalloo, U., Nyamande, K., Gajee, K., Sturm, A.W., et al. Probable mother to infant transmission of Pneumocystis jiroveci from an HIV-infected woman to her HIV-uninfected infant. Aids 19 (2005), 1548–1549.
27. [27] Shiri, T., Auranen, K., Nunes, M.C., Adrian, P.V., van Niekerk, N., de Gouveia, L., et al. Dynamics of pneumococcal transmission in vaccine-naive children and their HIV-infected or HIV-uninfected mothers during the first 2 years of life. Am J Epidemiol 178 (2013), 1629–1637.
28. [28] Cotton, M.F., Schaaf, H.S., Lottering, G., Weber, H.L., Coetzee, J., Nachman, S., et al. Tuberculosis exposure in HIV-exposed infants in a high-prevalence setting. Int J Tuberc Lung Dis 12 (2008), 225–227.
29. [29] UNICEF. Joint learning initiative on children and HIV/AIDS. Home truths. Facing the facts on children, AIDS and poverty; 2009.
30. [30] Bunders, M., Pembrey, L., Kuijpers, T., Newell, M.L., Evidence of impact of maternal HIV infection on immunoglobulin levels in HIV-exposed uninfected children. AIDS Res Hum Retroviruses 26 (2010), 967–975.
31. [31] Sela, M., Immunology in AIDS in 1990. Aids 4:Suppl. 1 (1990), S9–S14.
32. [32] Afran, L., Garcia Knight, M., Nduati, E., Urban, B.C., Heyderman, R.S., Rowland-Jones, S.L., HIV-exposed uninfected children: a growing population with a vulnerable immune system?. Clin Exp Immunol 176 (2014), 11–22.
33. [33] Scott, S., Moss, W.J., Cousens, S., Beeler, J.A., Audet, S.A., Mugala, N., et al. The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants. Clin Infect Dis 45 (2007), 1417–1424.
34. [34] Jones, C.E., Naidoo, S., De Beer, C., Esser, M., Kampmann, B., Hesseling, A.C., Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. Jama 305 (2011), 576–584.
35. [35] Reikie, B.A., Naidoo, S., Ruck, C.E., Slogrove, A.L., de Beer, C., la Grange, H., et al. Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life. Clin Vaccine Immunol 20 (2013), 33–38.
36. [36] Kenny, J., Musiime, V., Judd, A., Gibb, D., Recent advances in pharmacovigilance of antiretroviral therapy in HIV-infected and exposed children. Curr Opin HIV AIDS 7 (2012), 305–316.
37. [37] Le Chenadec, J., Mayaux, M.J., Guihenneuc-Jouyaux, C., Blanche, S., Enquete Perinatale Francaise Study G. Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants. Aids 17 (2003), 2053–2061.
38. [38] Siberry, G.K., Williams, P.L., Mendez, H., Seage, G.R. 3rd, Jacobson, D.L., Hazra, R., et al., Pediatric HIVACS. Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants. Aids 26 (2012), 1151–1159.
39. [39] Gibb, D.M., Kizito, H., Russell, E.C., Chidziva, E., Zalwango, E., Nalumenya, R., et al., team Dt. Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial. PLoS Med, 9, 2012, e1001217.
40. [40] Brogly, S., Williams, P., Seage, G.R. 3rd, Van Dyke, R., In utero nucleoside reverse transcriptase inhibitor exposure and cancer in HIV-uninfected children: an update from the pediatric AIDS clinical trials group 219 and 219C cohorts. J Acquir Immune Defic Syndr 41 (2006), 535–536.
41. [41] Gompels, U.A., Larke, N., Sanz-Ramos, M., Bates, M., Musonda, K., Manno, D., et al., Group CS. Human cytomegalovirus infant infection adversely affects growth and development in maternally HIV-exposed and unexposed infants in Zambia. Clin Infect Dis 54 (2012), 434–442.
42. [42] Meyer, S.A., Westreich, D.J., Patel, E., Ehlinger, E.P., Kalilani, L., Lovingood, R.V., et al. Postnatal cytomegalovirus exposure in infants of antiretroviral-treated and untreated HIV-infected mothers. Infect Dis Obstet Gynecol, 2014, 2014, 989721.
43. [43] Mussi-Pinhata, M.M., Motta, F., Freimanis-Hance, L., de Souza, R., Szyld, E., Succi, R.C., et al., Group NPS. Lower respiratory tract infections among human immunodeficiency virus-exposed, uninfected infants. Int J Infect Dis 14:Suppl. 3 (2010), e176–e182.
44. [44] Cohen, C., Moyes, J., Tempia, S., Groome, M., Walaza, S., Pretorius, M., et al. Epidemiology of acute lower respiratory tract infection in HIV-exposed uninfected infants. Pediatrics, 2016, 137.
45. [45] Koyanagi, A., Humphrey, J.H., Ntozini, R., Nathoo, K., Moulton, L.H., Iliff, P., et al., Group ZS. Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy. Pediatr Infect Dis J 30 (2011), 45–51.
46. [46] Marquez, C., Okiring, J., Chamie, G., Ruel, T.D., Achan, J., Kakuru, A., et al. Increased morbidity in early childhood among HIV-exposed uninfected children in Uganda is associated with breastfeeding duration. J Trop Pediatr 60 (2014), 434–441.
47. [47] Le Roux, S., Abrams, E.J., Nguyen, K., Myer, L., Clinical outcomes of HIV-exposed, -uninfected children in sub-Saharan Africa. Trop Med Int Health, 2016.
48. [48] le Roux, D.M., Myer, L., Nicol, M.P., Zar, H.J., Incidence and severity of childhood pneumonia in the first year of life in a South African birth cohort: the Drakenstein Child Health Study. Lancet Global Health 3 (2015), e95–e103.
49. [49] Shapiro, R.L., Lockman, S., Kim, S., Smeaton, L., Rahkola, J.T., Thior, I., et al. Infant morbidity, mortality, and breast milk immunologic profiles among breast-feeding HIV-infected and HIV-uninfected women in Botswana. J Infect Dis 196 (2007), 562–569.
50. [50] Slogrove, A.L., Goetghebuer, T., Cotton, M.F., Singer, J., Bettinger, J.A., Pattern of infectious morbidity in HIV-exposed uninfected infants and children. Front Immunol, 7, 2016, 164.
51. [51] Slogrove, A., Esser, M.M., Cotton, M.F., Speert, D.P., Kollman, T.R., Singer, J., et al. A prospective cohort study of common childhood infections in South African HIV exposed uninfected and HIV unexposed infants. Pediatr Infect Dis J, 2016 in press.
52. [52] Kelly, M.S., Wirth, K.E., Steenhoff, A.P., Cunningham, C.K., Arscott-Mills, T., Boiditswe, S.C., et al. Treatment failures and excess mortality among HIV-exposed, uninfected children with pneumonia. J Pediatric Infect Dis Soc 4 (2015), e117–e126.
53. [53] McNally, L.M., Jeena, P.M., Gajee, K., Thula, S.A., Sturm, A.W., Cassol, S., et al. Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet 369 (2007), 1440–1451.
54. [54] Cohen, C., Walaza, S., Moyes, J., Groome, M., Tempia, S., Pretorius, M., et al. Epidemiology of viral-associated acute lower respiratory tract infection among children <5 years of age in a high HIV prevalence setting, South Africa, 2009–2012. Pediatr Infect Dis J 34 (2015), 66–72.
55. [55] Zar, H.J., Barnett, W., Stadler, A., Gardner-Lubbe, S., Myer, L., Nicol, M.P., Aetiology of childhood pneumonia in a well vaccinated South African birth cohort: a nested case-control study of the Drakenstein Child Health Study. Lancet Respir Med, 2016 pii: S2213-2600(2216)00096-00095.
56. [56] Madhi, S.A., Nachman, S., Violari, A., Kim, S., Cotton, M.F., Bobat, R., et al., Team PS. Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children. N Engl J Med 365 (2011), 21–31.
57. [57] Muloiwa, R., Dube, F.S., Nicol, M.P., Zar, H.J., Hussey, G.D., Incidence and diagnosis of pertussis in South African children hospitalized with lower respiratory tract infection. Pediatr Infect Dis J 35 (2016), 611–616.
58. [58] Hsiao, N.Y., Zampoli, M., Morrow, B., Zar, H.J., Hardie, D., Cytomegalovirus viraemia in HIV exposed and infected infants: prevalence and clinical utility for diagnosing CMV pneumonia. J Clin Virol 58 (2013), 74–78.
59. [59] Morrow, B.M., Hsaio, N.Y., Zampoli, M., Whitelaw, A., Zar, H.J., Pneumocystis pneumonia in South African children with and without human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Pediatr Infect Dis J 29 (2010), 535–539.
60. [60] Shapiro, R.L., Hughes, M., Powis, K., Ajibola, G., Bennett, K., Moyo, S., et al. Similar mortality with cotrimoxazole vs. placebo in HIV-exposed uninfected children. Conference on Retroviruses and Opportunistic Infections, Boston, 2016.
61. [61] Cranmer, L.M., Kanyugo, M., Jonnalagadda, S.R., Lohman-Payne, B., Sorensen, B., Maleche Obimbo, E., et al. High prevalence of tuberculosis infection in HIV-1 exposed Kenyan infants. Pediatr Infect Dis J 33 (2014), 401–406.
62. [62] von Mollendorf, C., von Gottberg, A., Tempia, S., Meiring, S., de Gouveia, L., Quan, V., et al., Group for Enteric R, Meningeal Disease Surveillance in South A. Increased risk for and mortality from invasive pneumococcal disease in HIV-exposed but uninfected infants aged <1 year in South Africa, 2009–2013. Clin Infect Dis 60 (2015), 1346–1356.
63. [63] Almeida Vde, C., Negrini, B.V., Cervi, M.C., Isaac Mde, L., Mussi-Pinhata, M.M., Pneumococcal nasopharyngeal carriage among infants born to human immunodeficiency virus-infected mothers immunized with pneumococcal polysaccharide vaccine during gestation. Pediatr Infect Dis J 30 (2011), 466–470.
64. [64] Gray, D., Turkovic, L., Willemse, L., Visagie, A., Vanker, A., Stein, D.J., et al. Lung function in African infants in the Drakenstein Child Health Study: impact of lower respiratory tract infection. Am J Respir Crit Care Med, 2016 Submitted March 2016.